PKI PerkinElmer Inc.

CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020
EN
12/10/2020

Underlying

PKIPerkinElmer Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PerkinElmer Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.27
DHR DANAHER CORPORA...
ILMN ILLUMINA INC. ... (+17)

Vermilion Compass: Weekly Equity Strategy

6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...

DHR DANAHER CORPORATION
ILMN ILLUMINA INC.
WAT WATERS CORPORATION
TECH BIO-TECHNE CORPORATION
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC.
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
BRKR BRUKER CORPORATION
A AGILENT TECHNOLOGIES INC.
BIO BIO-RAD LABORATORIES INC. CLASS A
PKI PERKINELMER INC.
NTLA INTELLIA THERAPEUTICS INC.
CRSP CRISPR THERAPEUTICS AG
AVTR AVANTOR INC.
PSNL PERSONALIS
TWST TWIST BIOSCIENCE
PGEN PRECIGEN INC
OGEN ORAGENICS INC.
10/23/25 October 23, 2025 1 EN
PKI PerkinElmer In...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Revvity, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 24 June 2025 in which we reassessed the appropriateness of the ratings in the context of the ...

PKI PERKINELMER INC.
06/25/25 June 25, 2025 1 EN
 PRESS RELEASE
Free
PKI PerkinElmer In...

Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with N...

WALTHAM, Mass.--(BUSINESS WIRE)-- (NYSE: RVTY), announced today that its business has launched the (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. Now available in countries accepting the CE mark, this all-in-one solution increases the efficiency of the entire IIFT process, encompassing sample preparation, incubation, washing and mounting of slides as well as image acquisition and analysis. “Traditional IIFT processing can be tedious and time-consuming, requiring the expertise of specially trained lab technicians and a dark room,”...

June 1, 2023 1 EN
EUR 648.98
PKI PerkinElmer In...

PerkinElmer, Inc. - January 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

PKI PERKINELMER INC.
03/28/23 March 28, 2023 1 EN
EUR 648.98
PKI PerkinElmer In...

PerkinElmer, Inc. - October 2022 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

PKI PERKINELMER INC.
12/16/22 December 16, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch